EBOS Group Reports Full Year 2025 Earnings

EBOS Group (NZSE:EBO) Full Year 2025 Results

Key Financial Results

• Revenue: AU$12.3b (down 7.0% from FY 2024).
• Net income: AU$215.1m (down 21% from FY 2024).
• Profit margin: 1.8% (down from 2.1% in FY 2024). The decrease in margin was driven by lower revenue.

This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

All figures shown in the chart above are for the trailing 12 month (TTM) period

EBOS Group Earnings Insights

Looking ahead, revenue is forecast to grow 5.0% p.a. on average during the next 3 years, compared to a 7.4% growth forecast for the Healthcare industry in New Zealand.

Performance of the New Zealander Healthcare industry.

The company's shares are down 16% from a week ago.

Balance Sheet Analysis

Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We've done some analysis and you can see our take on EBOS Group's balance sheet.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.